• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

HHS Awards $12.2M to Expand COVID-19 Testing in Georgia

Share:

May 13, 2020

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), awarded $12,280,445 to 35 health centers in Georgia, to expand COVID-19 testing. Today’s funding for health centers is part of the Paycheck Protection Program and Health Care Enhancement Act, signed into law by President Trump on April 24th. The legislation provides funding for small businesses and individuals financially affected by COVID-19, additional funding for hospitals and healthcare providers, and increased testing capabilities to help track the spread and impact of the coronavirus.

HRSA-funded health centers will use this funding to expand the range of testing and testing-related activities to best address the needs of their local communities, including the purchase of personal protective equipment; training for staff, outreach, procurement and administration of tests; laboratory services; notifying identified contacts of infected health center patients of their exposure to COVID-19; and the expansion of walk-up or drive-up testing capabilities.

Across the nation, nearly $583 million was awarded to 1,385 HRSA-funded health centers in all 50 states, the District of Columbia, and eight U.S. territories to support their testing capacity. Nearly 88 percent of HRSA-funded health centers report testing patients, with more than 65 percent offering walk-up or drive-up testing. Health centers are currently providing more than 100,000 weekly COVID-19 tests in their local communities.

“This new funding secured by President Trump will expand the work health centers are doing to test Americans for COVID-19,” said HHS Secretary Alex Azar. “Widespread testing is a critical step in reopening America, and health centers are vital to making testing easily accessible, especially for underserved and minority populations. Further, because health centers can help notify contacts of patients who test positive, they will continue playing an important role in cooperating with state and local public health departments.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: HIT Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • MRI Interventions, Inc. Closes $17.5 Million Strategic Investment from PTC Therapeutics, Inc. and Petrichor Healthcare Capital ManagementMRI Interventions, Inc. Closes $17.5 Million Strategic Investment from PTC Therapeutics, Inc. and Petrichor Healthcare Capital Management
  • Companion Diagnostics Development Services Market : Distribution By Type of Service Offered, Analytical Technique Used, Therapeutic Areas and Key Geographies : Industry Trends and Global Forecasts, 2022-2035Companion Diagnostics Development Services Market : Distribution By Type of Service Offered, Analytical Technique Used, Therapeutic Areas and Key Geographies : Industry Trends and Global Forecasts, 2022-2035
  • DUOS Raises $10M to Empower Older Adults to Live IndependentlyDUOS Raises $10M to Empower Older Adults to Live Independently
  • Siemens Acquires Brightly for $1.57B to Enhance Built InfrastructureSiemens Acquires Brightly for $1.57B to Enhance Built Infrastructure
  • VBL Therapeutics Announces that S-4 Registration Statement for Proposed Merger with Notable Labs Is Declared Effective by SECVBL Therapeutics Announces that S-4 Registration Statement for Proposed Merger with Notable Labs Is Declared Effective by SEC
  • GSK – GlaxoSmithKline plc: GSK to divest Horlicks and other Consumer Healthcare nutrition products to UnileverGSK – GlaxoSmithKline plc: GSK to divest Horlicks and other Consumer Healthcare nutrition products to Unilever
  • Weekend Unlimited Completes Acquisition Of Jamaican AssetsWeekend Unlimited Completes Acquisition Of Jamaican Assets
  • Q&A: How Carbon Health Plans to Modernize ‘Disconnected’ Chronic CareQ&A: How Carbon Health Plans to Modernize ‘Disconnected’ Chronic Care

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications